Novamed Company
"Microorganism Diagnostic Systems."
Novamed has developed proprietary diagnostic systems, including the patented and FDA-approved DipStreak and Diaslide culture devices for the rapid diagnosis of urinary tract infections, and NovaStreak, for the detection of microorganisms in food and dairy products.
Combating Coronavirus Pandemic
Novamed's solution helps address the Coronavirus Pandemic. Novamed Ltd, an Israeli life sciences company operating in the in-vitro rapid diagnostics market is developing a home diagnostics kit for COVID-19.
Novamed has developed proprietary diagnostic systems, including the patented and FDA-approved DipStreak and Diaslide culture devices for the rapid diagnosis of urinary tract infections, and NovaStreak, for the detection of microorganisms in food and dairy products.
Combating Coronavirus Pandemic
Novamed's solution helps address the Coronavirus Pandemic. Novamed Ltd, an Israeli life sciences company operating in the in-vitro rapid diagnostics market is developing a home diagnostics kit for COVID-19.
Technology:
COVID Treatments
Industry:
Preventive Tech
Headquarters:
Israel
Founded Date:
1995
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership